View in EDS

AAV transduction of human glioblastoma cell lines induces perturbation in cell proliferation.

Saved in:
Bibliographic Details
Title: AAV transduction of human glioblastoma cell lines induces perturbation in cell proliferation.
Authors: Wu A; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Dumo CJ; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Cook WH; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Richards I; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Macapagal Foliaki J; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Cooper E; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Fong DM; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Mouravlev A; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Park TI; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Dragunow M; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand., Young D; Department of Pharmacology & Clinical Pharmacology, The University of Auckland, Auckland 1023, New Zealand.; Centre for Brain Research, The University of Auckland, Auckland 1023, New Zealand.
Source: Molecular therapy. Oncology [Mol Ther Oncol] 2026 Apr 22; Vol. 34 (2), pp. 201216. Date of Electronic Publication: 2026 Apr 22 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2950-3299
DOI:10.1016/j.omton.2026.201216